GLP-1 Medications and the Questions Emerging Around Their Side Effects in atlanta

GLP-1 receptor agonists have changed the landscape of medical weight management. Medications such as semaglutide and tirzepatide can help eligible patients achieve significant weight loss by influencing appetite, satiety, gastric emptying, and metabolic processes. For many people, these medications have provided an effective tool for addressing obesity and its associated health risks.

At the same time, the rapid growth in GLP-1 use has led researchers to examine potential adverse effects more closely. Most commonly discussed side effects involve the gastrointestinal system, including nausea, vomiting, diarrhea, constipation, and abdominal discomfort. However, researchers have also begun investigating less common concerns, including whether certain GLP-1 medications may be associated with changes affecting the eyes or optic nerve.

For patients considering or currently using GLP-1 medications, the appropriate response is not necessarily to avoid treatment altogether. Instead, understanding the available evidence and maintaining communication with the physician managing the medication can help patients make informed decisions about their health.

What Does the Research Say About GLP-1 Medications and Eye Health?

One study that drew increased attention to this issue was published in JAMA Ophthalmology in 2024. Researchers examined medical records and reported an association between semaglutide use and non-arteritic anterior ischemic optic neuropathy, commonly abbreviated as NAION.

NAION occurs when blood flow to part of the optic nerve is disrupted. It can cause sudden, typically painless vision loss and is an ophthalmic condition that requires prompt medical evaluation. The study did not prove that semaglutide causes NAION. Observational research can identify patterns and associations, but it cannot establish a direct cause-and-effect relationship on its own.

Subsequent research and regulatory attention have continued to examine the potential relationship between GLP-1 therapies and optic nerve disorders. The evidence remains evolving, and patients should be cautious about interpreting individual studies as definitive proof of risk. Patients should discuss their individual risk factors, medical history, and treatment options with their prescribing physician rather than making medication decisions based solely on an isolated study or media report.

Why Weight Loss Can Change the Way Your Body Looks

The conversation surrounding GLP-1 medications is not limited to medication side effects. Significant weight loss itself can create aesthetic changes that patients may not anticipate when they begin treatment. When the body loses a substantial amount of fat, the skin does not always contract at the same rate. Skin stretched for an extended period may have reduced elasticity, leaving lax or loose tissue behind. The extent of this change depends on factors such as the amount and speed of weight loss, age, genetics, sun exposure, skin quality, and how long the tissue has remained stretched.

Patients may also notice that their body looks different even after reaching a healthier weight. Areas that once appeared fuller may become flatter, while loose skin, residual fat deposits, and cellulite may become more noticeable. This is where the distinction between weight loss and body contouring becomes important. GLP-1 medications are intended to help with weight management. Body-contouring treatments address the appearance of specific areas after or during weight changes. They do not replace a healthy weight-management strategy, and they are not intended to produce the same type of systemic weight loss as medication.

CoolSculpting Elite: Addressing Stubborn Fat After Weight Loss

One of the most recognizable non-surgical body-contouring technologies is CoolSculpting Elite. Rather than producing generalized weight loss, CoolSculpting Elite is designed to reduce localized pockets of fat that remain resistant to diet and exercise.

The technology uses controlled cooling to target fat cells beneath the skin. Fat cells are more susceptible to controlled cold exposure than surrounding tissues, allowing the treatment to target the selected area without surgery. Over time, the body naturally processes the affected fat cells.

This makes CoolSculpting Elite fundamentally different from a GLP-1 medication. A GLP-1 medication works throughout the body through metabolic and appetite-related pathways, while CoolSculpting Elite is a localized aesthetic treatment intended to contour specific areas. At Keller Aesthetics, CoolSculpting Elite can be part of a broader body-contouring strategy for patients in the Atlanta and Sandy Springs area who have reached a relatively stable weight but still notice localized areas they want to refine.

Morpheus8 for Skin Tightening and Post-Weight-Loss Laxity

Reducing excess fat does not necessarily tighten the skin overlying the treatment area. For patients whose primary concern is laxity rather than residual fat, Morpheus8 approaches the problem differently. Morpheus8 combines microneedling with radiofrequency energy. Tiny needles deliver controlled energy beneath the skin, creating a thermal stimulus within targeted tissue layers. This process is intended to encourage collagen remodeling and improve the skin’s structural qualities over time.

As collagen production and organization change with age, weight fluctuations, and environmental exposure, skin can lose firmness and resilience. Treatments that stimulate controlled remodeling may help improve the appearance of laxity and texture in appropriately selected patients. Morpheus8 is particularly relevant for patients who notice their skin has become looser after significant weight loss but do not necessarily require surgical skin removal. Because the treatment relies partly on the body’s remodeling response, patients may see continued changes over the weeks and months following a treatment series.

VelaShape III: A Different Approach to Cellulite and Body Reshaping

Cellulite presents another challenge after weight loss. Even when someone reaches a healthy or desired weight, the dimpled appearance of cellulite can remain because cellulite is not simply excess body fat. VelaShape III is designed specifically around this distinction. The system combines infrared light, bipolar radiofrequency energy, and mechanical tissue manipulation to address the appearance of cellulite and improve body contour.

The radiofrequency and infrared components deliver controlled energy to the treatment area, while the mechanical component massages and manipulates the tissue. Together, these technologies are intended to improve the appearance of the skin and underlying tissue while temporarily reducing the appearance of cellulite and, in appropriate treatment areas, circumference. VelaShape III therefore occupies a different position from both CoolSculpting Elite and Morpheus8. CoolSculpting Elite primarily targets localized fat. Morpheus8 focuses on collagen remodeling and skin quality. VelaShape III primarily addresses the appearance of cellulite and overall contour.

Why These Treatments May Be Considered Together

Post-weight-loss body changes rarely involve only one issue. A patient may reach a stable weight and find three concerns more apparent: a small amount of stubborn fat, looser skin, and cellulite. Because CoolSculpting Elite, Morpheus8, and VelaShape III address different aspects of body contouring, they may sometimes be incorporated into a broader treatment plan. The goal is not to combine treatments simply to add procedures. Instead, the objective is to match each technology to the specific tissue characteristic contributing to the patient’s concern.

For example, CoolSculpting Elite may be considered when a localized fat deposit remains. Morpheus8 may be more appropriate when reduced firmness and skin laxity are the primary concerns. VelaShape III may be considered when cellulite and uneven surface contour are the dominant issues. Treatment sequencing matters as well. The appropriate combination depends on the treatment areas, the patient’s anatomy, skin quality, medical history, current weight stability, and desired outcome.

How GLP-1 Weight Loss and Body Contouring Fit Into the Bigger Picture

It is tempting to view GLP-1 medications and aesthetic treatments as competing approaches, but they serve fundamentally different purposes. GLP-1 medications are medical therapies used for weight management and, depending on the specific medication and indication, treatment of certain metabolic conditions. CoolSculpting Elite, Morpheus8, and VelaShape III are aesthetic technologies intended to address specific concerns involving fat distribution, skin quality, cellulite, and body contour.

None of these aesthetic treatments should be presented as a replacement for medically appropriate weight-management treatment. Likewise, achieving significant weight loss does not automatically resolve every aesthetic concern associated with changes in body composition. For some patients, the most meaningful aesthetic changes occur after weight has stabilized. This allows the provider to evaluate which concerns remain and develop a treatment strategy based on the patient’s new body composition rather than trying to predict how the tissues will change during ongoing weight loss.

What Should You Consider Before Choosing a Body-Contouring Treatment?

The right treatment begins with identifying the actual source of the concern. A body area that appears larger or less defined may involve fat, loose skin, cellulite, or a combination of all three. During a consultation, a qualified provider can assess skin elasticity, fat distribution, tissue quality, and the degree of contour irregularity. These factors help determine whether a non-surgical treatment is likely to produce a meaningful improvement.

It is equally important to maintain realistic expectations. Non-surgical body contouring is not equivalent to surgical excision of excess skin, and no device can guarantee a specific degree of fat reduction or skin tightening. Patients with substantial excess skin may ultimately require a surgical approach to achieve the degree of correction they want.

Why Choose Keller Aesthetics?

Travis Keller is a board-certified medical esthetician and cosmetic laser practitioner with more than 20 years of experience working with aesthetic and energy-based technologies. His experience allows consultations to focus on the underlying reason a patient is seeking treatment rather than simply matching a concern to the latest device.

That distinction matters even more after significant weight loss. The treatment that makes sense for someone with residual fat may not be the same treatment that makes sense for someone whose primary concern is lax skin or cellulite. At Keller Aesthetics, patients throughout Atlanta and Sandy Springs can discuss these concerns in the context of their individual anatomy, treatment history, and goals. The focus is on developing a realistic plan based on what each technology can accomplish.

Schedule a Consultation

If you have experienced significant weight loss and are now noticing stubborn fat, loose skin, cellulite, or changes in your body contour, understanding the differences between available treatments can help you make a more informed decision. Keller Aesthetics offers CoolSculpting Elite, Morpheus8, and VelaShape III for patients seeking non-surgical options for targeted body contouring and skin quality concerns in the Atlanta and Sandy Springs area.

Travis Keller and the Keller Aesthetics team can evaluate your individual concerns and explain which technologies may be appropriate based on your anatomy, skin quality, and goals. Schedule a consultation with Keller Aesthetics to discuss your options and develop a personalized approach to body contouring after weight loss.